Physical Activity Intervention for Lung Cancer Survivors
NCT ID: NCT00717795
Last Updated: 2023-06-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
52 participants
OBSERVATIONAL
2008-06-10
2023-06-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Web-based Physical Activity Intervention for Young Adult Cancer Survivors
NCT00791375
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer Survivors
NCT07215091
Be-Active Study - Increasing Physical Activity in Cancer Survivors
NCT05376293
Physical Activity Promotion in Cancer Follow-Up Care
NCT00230711
A Study of Physical Activity in Cancer Survivors
NCT05988892
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Arm 1 - Physical Activity intervention
interview and physical activity
For Arm 1 participants in the Physical Activity intervention condition will be assessed at baseline, and postintervention Follow-up (at 12 weeks post baseline).
2
Arm 2 - Wait-list control
interview and wait list
Participants in the control condition (Arm 2)will be assessed at baseline and 12 weeks post baseline (Follow-up). At this time, the PA intervention will be offered at no cost to the participants in the control condition. If the waitlist participant chooses to complete the PA intervention after the 12 week waitlist period, program satisfaction will be assessed after study completion.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
interview and physical activity
For Arm 1 participants in the Physical Activity intervention condition will be assessed at baseline, and postintervention Follow-up (at 12 weeks post baseline).
interview and wait list
Participants in the control condition (Arm 2)will be assessed at baseline and 12 weeks post baseline (Follow-up). At this time, the PA intervention will be offered at no cost to the participants in the control condition. If the waitlist participant chooses to complete the PA intervention after the 12 week waitlist period, program satisfaction will be assessed after study completion.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* At least one year post thoracic surgical resection;
* Have no evidence of NSCLC or any other cancer at the time of study enrollment and not receiving any cancer treatment;
* Currently sedentary or insufficiently active, defined by the American College of Sports Medicine (ACSM) and the Centers for Disease Control and Prevention as less than a total of 150 minutes of at least moderate intensity PA per week;
* Able to complete a six-minute walk test (6MWT);
* Able to provide informed consent.
FOCUS GROUP ONLY:
• Completed the Physical Activity program offered through this study (08067);
Exclusion Criteria
* regular use of an ambulatory aid (cane or walker);
* resting oxygen saturation less than 88%;
* inability to walk due to severe arthritis or other musculoskeletal problems;
* a diagnosis of unstable angina in the previous 6 weeks;
* a heart attack, angioplasty or heart surgery in the previous 3 months;
* current heart rate \<50 or \>120 at rest; current uncontrolled hypertension;
* current significant valvular heart disease or decompensated congestive heart failure and
* patient reported pain of any origin that would preclude participation in the proposed PA intervention
* Evidence of significant medical cognitive or psychiatric disturbance sufficient, in the investigator's judgment, to preclude participation in the intervention
* Self-reporting of greater than 60 minutes of vigorous activity per week or 150 minutes of moderate intensity PA per week.
* Patient resides at more than two hours travel distance from the Center
* Insufficient English fluency to complete evaluation tools.
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fox Chase Cancer Center
OTHER
University of Alberta
OTHER
Brown University
OTHER
Memorial Sloan Kettering Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jamie Ostroff, PhD
Role: PRINCIPAL_INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Memorial Sloan Kettering Cancer Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
08-067
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.